A multi-centre, open-label innovation study in pancreatic cancer utilising Nanoknife® System for Irreversible Electroporation (IRE) in unresectable stage 3 pancreatic adenocarcinoma (ACTRN12621000955819)
DIRECT/InspIRE Australia
This trial is Currently recruiting
Registration number ACTRN12621000955819
Program & service
This trial is being run with the Radiology & Nuclear Medicine service, and as part of the Radiology & Nuclear Medicine program.
Trial phase
Other
Trial participation type
This trial is for clinical research of something other than a drug or device.
Principal investigator
Professor Samantha Ellis, Associate Professor Charles Pilgrim
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTRIf you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.